Methylation of the PRKD1 promoter has been linked to silencing seen in breast cancer tumor progression, and targeted upregulation of PRKD1 has been suggested as an approach to reduce breast cancer invasiveness [32]. This evidence concerns the gene PRKD1 and breast carcinoma.